Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
-
Taseko to Release Fourth Quarter and Year End 2024 Results
-
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
-
Kestra Medical Technologies, Ltd. Appoints Al Ford as Chief Commercial Officer
-
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
-
ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
-
Constellium Announces Price Increase for Shipments of Flat Rolled Products in the US
-
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
-
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
-
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
-
Allegro MicroSystems to Present at Morgan Stanley’s Technology, Media & Telecom Conference on March 4, 2025
-
Rujo Boots Steps into a New Era of Ecommerce with Nogin’s Fully Managed Solution
-
FDH Aero Names Ian Walsh as Chief Executive Officer
-
Voltus, Vurge Announce Partnership to Deliver Comprehensive Utility Cost Optimization for Commercial Customers
-
Crown LNG Signs Gas Sales MOU with India Gas Exchange
-
DIRTT to Announce Fourth Quarter 2024 Financial Results on February 26, 2025
-
Mobiquity Technologies and Context Networks Strengthen Casino Ad Tech Leadership with Strategic Equity Investment
-
Advanced Flower Capital Provides $15 Million Senior Secured Credit Facility to Story Ohio
-
ALX Oncology to Host Virtual R&D Day on March 5, 2025
-
Harsco Environmental Secures Contract with İzmir Demir Çelik Sanayi A.Ş. (İDÇ)
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
New Survey: Behavior Change Programs are the Most Important Employee Benefit for Chronic Disease Prevention and Management
-
Dycom Industries, Inc. Appoints Jill L. Ramshaw as Vice President and Chief Human Resources Officer
-
PubMatic to Participate in Upcoming Financial Conferences
-
Solid Power, Inc. Announces Timing of Full Year 2024 Earnings Release and Conference Call
-
Safepoint Holdings Migrates to Duck Creek OnDemand to Drive Operational Efficiency and Growth
-
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
-
Daxor to Exhibit at World's Largest Critical Care Conference
-
Esperion to Report Fourth Quarter and Full Year 2024 Financial Results on March 4
-
Arcadia Enables High-Value Care with Advanced Interoperability and AI Solutions
-
Lottery.com Announces Global Advisory Board to Support Growth Initiatives
-
Notification of major holdings
-
Big Happy Welcomes Ad Tech Veteran Neil Ford as Head of Sales for Midwest and West Coast Amid Record-Breaking Growth
-
Form 8.3 - [THRUVISION GROUP PLC- 17 02 2025] - (CGAML)
-
Exco Technologies Limited Announces Normal Course Issuer Bid
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 17 02 2025] - (CGWL)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 17 02 2025] - (CGWL)
-
REPEAT -- Cycurion Lists on NASDAQ (CYCU) and Provides Corporate Update
-
ParaZero Moving Forward to Phase II with Israeli Ministry of Defense with the Precision Airdrop System Project
-
Form 8.3 - Assura Plc
-
American Tungsten Corp. Announces Potential Partnership for Processing & Milling in Philipsburg, Montana
-
FTI Consulting Expands Transactions Practice with Appointment of Two M&A Experts
-
FTI Consulting Expands Transactions Practice with Appointment of Two M&A Experts
-
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
-
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
-
Hillman Reports Record Fourth Quarter 2024 Results; Provides 2025 Guidance
-
Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details
-
Watsco Reports Record Fourth Quarter Sales, Expanded Margins and Record Cash Flow
-
Watsco Boosts Annual Dividend 11% to $12.00 Per Share
-
Stallion Uranium Announces New Consolidation Ratio
